Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP230 represents a pseudogene homolog of the functional RNA, 7SK small nuclear, encoded by the RN7SK gene. Pseudogenes are non-functional segments of DNA that resemble functional genes but are generally not transcribed into functional RNA or protein. The functional 7SK RNA, encoded by the RN7SK gene, plays a key regulatory role in transcription elongation by forming the 7SK small nuclear ribonucleoprotein (snRNP) complex, regulating the activity of positive transcription elongation factor b (P-TEFb), and thus controls RNA polymerase II-dependent transcription. However, RN7SK pseudogene 230 itself does not encode a functional RNA or protein product, nor does it participate in any established biological processes, signaling pathways, or disease mechanisms. There are no approved drugs or experimental agents known to target RN7SK pseudogenes, and these sequences are not considered canonical therapeutic targets. Summary of interpretation and notable issues: - RN7SKP230 is a genetically annotated pseudogene, meaning it is essentially a "dead gene"—it does not encode a functional product or serve as a receptor, enzyme, transporter, or any other pharmacologically actionable molecule. - As such, it is not a therapeutic target, and the entry is incorrect or inadequate as a drug target. - Entries regarding 7SK RNA or the protein components of the 7SK snRNP are functionally relevant in gene regulation and certain diseases, but these refer to the functional RN7SK gene (not this pseudogene). If you are seeking information about the real target (7SK RNA or 7SK snRNP), please clarify and refer to the functional RN7SK gene. Otherwise, RN7SKP230 as a pseudogene holds no recognized function, disease link, or druggability in current biomedical science.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear, pseudogene 230 (RN7SKP230).